Chiral phosphine ligands

13885-09-1, 2-(Diphenylphosphino)biphenyl is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

A solution of CuI (0.019 g, 0.1 mmol) in CH3CN(5 mL) wasadded to a stirred solution of 1,10-phenanthroline (0.018 g,0.1 mmol) and 2-(Dpp)bp (0.034 g, 0.1 mmol) in EtOAc(5 mL). The mixture was stirred for 5 min and then the precipitatewas filtered off. The resultant clear solution was setaside for evaporation in air. Orange block crystals of complex1 were obtained after 1 day and red crystals of complex2 were obtained the next day. These two different productswere separated manually under a microscope. Yield: 20.0 mg(28.2percent, based on Cu) for 1 and 24.4 mg (27.1percent, based onCu) for 2. Anal. Calc. for 1 C36H27N2P1Cu1I1:C, 60.98; H,3.81; N, 3.95. Found (percent): C, 61.04; H, 3.81; N, 3.88. IR(KBr pellet, cm?1): 3446sh, 3004s, 1789m, 1639m, 1550s,1448m, 1209w, 1120m, 716m; for 2 C36H27N2P1Cu2I2:C,48.07; H, 3.03; N, 3.12. Found (percent): C, 48.14; H, 3.04; N,3.04. IR (KBr pellet, cm?1): 3522sh, 3004s, 1639w, 1461m,1221s, 930s, 868s.

13885-09-1, 13885-09-1 2-(Diphenylphosphino)biphenyl 12976978, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Chen, Di; Chai, Wen-Xiang; Song, Li; Transition Metal Chemistry; vol. 43; 6; (2018); p. 517 – 527;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

12150-46-8, 1,1-Bis(diphenylphosphino)ferrocene is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

DPPF (55 mg, 0.1 mmol) was added to a rapidly stirred, 10 mlCH2Cl2 suspension of RuCl2(PPh3)3 (96 mg, 0.1 mmol). A colorchange from purple-black to red was observed within a few minutes.The solutionwas stirred for 30 min, then a CH2Cl2 solution of2-aminopyridine (9.4 mg, 0.1 mmol) was added, giving an immediatecolor change to yellow-green. After a further 30 min, thesolvent was removed in vacuo and 5ml of diethyl ether (Et2O) wereadded. The yellow product was filtered off, washed twice withether (2 5 ml), and then dried under vacuum.

12150-46-8, The synthetic route of 12150-46-8 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Ge, Sai; Zhang, Jin; Zhao, Jianguo; Ulhaq, Imran; Ma, Guibin; McDonald, Robert; Journal of Organometallic Chemistry; vol. 879; (2019); p. 7 – 14;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1070663-78-3,Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine,as a common compound, the synthetic route is as follows.

1070663-78-3, EXAMPLE FORTY-THREE: Synthesis of BrettPhosPdPhBr (17); In a nitrogen filled glovebox, a solution of BrettPhos (1, 23.6 mg, 44 mumol), bromobenzene (30 muL) and THF (2 mL) was added to solid (COD)Pd(CH2SiPhMe2)2 (20.4 mg, 40 mumol) (COD = 1,5-cyclooctadiene) in an oven-dried 20 mL vial. (The THF used in this experiment was prepared as escribed in the general procedures set forth in Example 7, then sparged with N2 for 30 min and stored over activated 3 A molecular sieves in a glovebox prior to use.) Pan, Y.; Young, G. B. J Organomet. Chem. 1999, 577, 257 ‘. The vial was capped, and the resulting yellow solution was allowed to stand for 48 h at rt. After this time, pentane (8 mL) was layered on top of the THF solution and the vial was allowed to stand for 24 h resulting in the formation of crystals. After 24 h, the crystals were collected via vacuum filtration in the glovebox, and dried under vacuum to provide 17 (24 mg, 75%) as light-yellow needles as a THF mono-solvate: 1H NMR (400 MHz, CD2Cl2, mixture of rotomers) delta 7.26-7.29 (m, 2H – minor), 7.00-7.06 (m, major and minor), 6.82- 6.92 (m, major and minor), 6.75-6.79 (m, IH – minor, IH – major), 4.33 (s, 3H – minor), 3.79 (s, 3H -major), 3.59 (s, 3H – minor), 3.33 (s, 3H – major), 3.00-3.08 (m, IH – major), 2.88-2.92 (m, IH – major), 2.72-2.82 (m, 2H – major), 2.46-2.53 (m, 2H – major), 2.32- 2.37 (m, 2H -minor), 1.50-1.90 (m, major and minor), 1.05-1.45 (m), 0.75-0.90 (m, 12H – major and minor), 0.55-0.65 (m, 2H – minor); 31P NMR (162 MHz, CD2Cl2, mixture of rotomers) delta 44.9 (minor), 36.9 (major).

1070663-78-3 Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine 25112535, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Patent; MASSACHUSETTS INSTITUTE OF TECHNOLOGY; WO2009/76622; (2009); A2;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.12150-46-8,1,1-Bis(diphenylphosphino)ferrocene,as a common compound, the synthetic route is as follows.

General procedure: A degassed dichloromethane (25.0?mL) solution of [RuCl2(PPh3)3] (96?mg; 0.10?mmol) and dppf (60.0?mg; 0.11?mmol), in a Schlenk flask, was stirred for 30?min followed by the addition of 0.10?mmol of the polypyridyl ligand. After 30?min of stirring the resulting solution was concentrated until ca. 5?mL and addition of 10?mL of diethyl ether afforded a solid, which was collected by filtration, washed with diethyl ether and dried under vacuum.

12150-46-8, 12150-46-8 1,1-Bis(diphenylphosphino)ferrocene 51341936, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Davila-Rodriguez, Maria?Jose; Barolli, Joao Paulo; de Oliveira, Katia Mara; Colina-Vegas, Legna; da Silva Miranda, Fabio; Castellano, Eduardo Ernesto; Von Poelhsitz, Gustavo; Batista, Alzir Azevedo; Archives of Biochemistry and Biophysics; vol. 660; (2018); p. 156 – 167;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.6372-42-5,Cyclohexyldiphenylphosphine,as a common compound, the synthetic route is as follows.,6372-42-5

General procedure: A. TfOCH2CF2H(0.514 g, 2.4 mmol) and triphenylphosphine (0.525 g, 2 mmol) were placed in aclosed Schlenk flask under a N2 atmosphere. The mixture was stirredat 120 oC for 24 h and cooled to room temperature. The resultingsolid was washed by diethyl ether, recrystallized from CH2Cl2/hexane,and dried in vacuum to give 0.66 g of (E)-ethene-1,2-diylbis(triphenylphosphonium)ditriflate (3a) as a white solid (0.78 mmol, 78%).2

As the paragraph descriping shows that 6372-42-5 is playing an increasingly important role.

Reference£º
Article; Wang, Shi-Meng; Han, Jia-Bin; Zhang, Cheng-Pan; Qin, Hua-Li; Tetrahedron Letters; vol. 56; 45; (2015); p. 6219 – 6222;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13440-07-8,Di(naphthalen-1-yl)phosphine oxide,as a common compound, the synthetic route is as follows.

Weigh 0.2 mmol of (E)-1,3-diphenylpropene, 0.3 mmol of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone into a 15 mL pressure-resistant reaction tube and add magnetic stirring. The mixture was reacted with 2 mL of nitromethane at room temperature for 5 min, monitored by TLC, and then reacted with 0.4 mmol of bis(naphthalen-1-yl)phosphine oxide for 6 h. After completion of the reaction, it was extracted with 20 ml of sodium sulfite solution, 10 mL of ethyl acetate, dried over anhydrous sodium sulfate at 20 C for 10 minutes and filtered, and finally distilled under reduced pressure at -0.09 MPa at 40 C to remove organics. The product (E)-(1,3-diphenylallyl)bis(naphthalen-1-yl)phosphine oxide was obtained as a solvent in a yield of 96%., 13440-07-8

As the paragraph descriping shows that 13440-07-8 is playing an increasingly important role.

Reference£º
Patent; Guangdong University of Technology; Wen Chunxiao; Chen Qian; Wang Xiaofeng; Yu Guodian; Huo Yanping; Zhang Kun; (15 pag.)CN108774263; (2018); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.719-80-2,Ethoxydiphenylphosphine,as a common compound, the synthetic route is as follows.

719-80-2, Under nitrogen, a mixture of 1 (115 mg, 0.138 mmol) and ethyl diphenylphosphinite (600 muL, 2.78 mmol) in a 25 mL flask was heated for 30 min at 100 C. Toluene (2 mL) was then added and the mixture was heated at reflux for 2 h. The product mixture was purified by column chromatography (silica gel) using a non-polar eluent (EtOAc/CH2Cl2, 1:1) to remove by-products and then a polar mixture (EtOAc/MeOH, 9:1) to separate the product. The eluate was concentrated and dried under vacuum to give a white solid foam 2 (175 mg, 95%).1HNMR (400 MHz, CDCl3) delta 7.71-7.66 (m, 12H, Ar-H), 7.50-7.39 (m, 18H, Ar-H),7.04 (dd, 3JHH=7.9 Hz, 4JHP=1.7 Hz, 6H, Ar-H), 6.97 (d, 3JHH = 7.9 Hz, 6H, Ar-H), 4.08 (q, J = 7.1 Hz, 6H, -COCH2CH3),3.65 (d, 2JHP =13.7 Hz, 6H, CH2P(O)Ph2),3.18 (d, J = 15.7 Hz, 6H, ArCHaHb), 2.95 (s,6H, ArCH2-), 2.80 (d, J = 15.7 Hz, 6H, ArCHaHb), 1.18 (t, J = 7.1 Hz, 9H, -COCH2CH3); 13C NMR (100MHz, CDCl3) delta 176.5 (s, -C=O), 136.8 (d, 5JCP = 2.6 Hz, Ar-C), 135.8 (s, Ar-C), 132.6 (d, 1JCP= 97.6 Hz, Ar-C), 132.2 (d, 4JCP = 2.4 Hz, Ar-C), 131.6 (d, 3JCP = 9.2 Hz, Ar-C), 130.4 (d, 3JCP = 4.8 Hz, Ar-C), 130.1 (d, 4JCP = 2.4 Hz, Ar-C), 129.9 (d, 2JCP = 8.0 Hz, Ar-C), 128.9 (d, 2JCP = 11.6 Hz, Ar-C), 61.1, 56.1, 43.7, 40.3, 38.1 (d, 1JCP = 66.2 Hz, CH2P(O)Ph2), 14.1;31P NMR (162 MHz, CDCl3) delta 31.2; HRMS-FAB (NOBA) Calcdfor C84H82O9P3 (M+H+): m/z (rel intensity) 1330.5272 (12.1%),1330.5248 (1.7%), 1329.5239 (40.8%), 1329.5214 (1.8%), 1328.5205 (90.9%),1327.5172 (100.0%),Observed: m/z (relintensity) 1330.5010 (M+4, 16), 1329.5145 (M+3, 44), 1328.5295 (M+2,90),1327.5162 (M+H+, 100), 1277.3716 (11), Elemental analysis: Calcd forC84H81O9P3: C, 76.00; H, 6.15; O,10.85; P, 7.00, Observed: C, 75.78; H, 6.20.

719-80-2 Ethoxydiphenylphosphine 69754, achiral-phosphine-ligands compound, is more and more widely used in various fields.

Reference£º
Article; Lim, Dong Seob; Sahoo, Suban K.; Cho, Chan Sik; Kim, Yang; Choi, Heung-Jin; Tetrahedron Letters; vol. 56; 41; (2015); p. 5665 – 5669;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13689-19-5,Tricyclohexylphosphine oxide,as a common compound, the synthetic route is as follows.

General procedure: NMR titration experiments of the guests HPCy3+, N-tosyldiallylamine (7) and Cy3P=O withsulfocalixarenes 1 as hosts: The titration experiments were performed at least in duplicate using a standard?constant guest? method in 600-640 muL D2O with addition of 7-10 muL MeOD-d4 or 10 muL DMSO-d6as internal standard (deltaH (MeOD-d4) = 3.31 ppm; deltaH (DMSO-d6) = 2.50 ppm) at room temperature. AllH-atoms of the guests HPCy3+, N-tosyldiallylamine (7) and Cy3P=O were evaluated using MestRe-C [32]and MestReNova [33]. Kass and log K values of the receptors were obtained by analysising the course ofthe chemical shifts of the protons of the guest HPCy3+, N-tosyldiallylamine (7) and Cy3P=O using theprogram HypNMR2008 [34,35].

13689-19-5, As the paragraph descriping shows that 13689-19-5 is playing an increasingly important role.

Reference£º
Article; Tomasek, Jasmine; Sessler, Miriam; Groeger, Harald; Schatz, Juergen; Molecules; vol. 20; 10; (2015); p. 19130 – 19141;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

4020-99-9, Methoxydiphenylphosphine is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

In 1000 ml by adding reaction bottle 95.2g (0.44mol) diphenylmethoxyphosphine and 77g (0.45mol) m-methoxybenzyl chloride making between, to elevate temperature under stirring condition 60 C, and in this temperature 12 hours, cooling to the end of the 20 C, directly enters the reaction of the next., 4020-99-9

The synthetic route of 4020-99-9 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Suzhou Chenghe Pharmaceutical & Chemical Co., Ltd.; Xia, Qiujing; (6 pag.)CN105541569; (2016); A;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

6372-42-5, Cyclohexyldiphenylphosphine is a chiral-phosphine-ligands compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,6372-42-5

General procedure: Complexes 4, 6, 8 and 10-12 were prepared by the following method. SacH (0.5mmol, 91.6mg) in water (5mL) was added to a solution of Pd(OAc)2 (0.25mmol, 56.1mg) in MeCN (10mL) and the solution was stirred for 30min at rt. Then, the corresponding phosphine (0.5mmol) in MeOH (10mL) was added to this solution and the resulting solutions were refluxed over a day. Complexes 2, 5 and 9 were synthesized using the same procedure, but the SacH/phosphine ratio was 2:1. In the case of 9, DMSO (10mL) was added to the reaction medium to dissolve the solid particles. The powders of these complexes were obtained after removal of the solvents using a rotary evaporator.

As the paragraph descriping shows that 6372-42-5 is playing an increasingly important role.

Reference£º
Article; Yilmaz, Veysel T.; Icsel, Ceyda; Turgut, Omer R.; Aygun, Muhittin; Evren, Enes; Ozdemir, Ismail; Inorganica Chimica Acta; vol. 500; (2020);,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate